Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 25;12(1):e057474.
doi: 10.1136/bmjopen-2021-057474.

Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data

Affiliations

Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data

Duduzile Edith Ndwandwe et al. BMJ Open. .

Abstract

Background: The Pan African Clinical Trials Registry (PACTR) is a WHO International Clinical Trials Registry Platform primary register, which caters for clinical trials conducted in Africa. PACTR is the first and, at present, the only member of the Network of WHO Primary Registers in Africa. The aim is to describe and report on the trends of trial records registered in PACTR.

Methods: PACTR was established in 2007 as the AIDS, Tuberculosis, and Malaria Clinical Trials Registry. The scope of the registry was then expanded in 2009 to include all diseases. This is a cross-sectional study of trials registered in PACTR from inception to 18 August 2021. A descriptive analysis of the use and trends of the following data fields: study intervention, disease condition, sex of the participants, sample size, ethics, funding and availability of results was conducted using Microsoft Excel.

Results: The number of trials registered has increased year on year, reaching 606 trials registered in 2020. The total number of trials registered at the time of the analysis was 2998. More than half of the trials in the registry (1655 of 2998, ie, 55%) were prospectively registered. Ethical approval was received by 90% (2691 of 2998) of the registered trials. Factorial assignment as an intervention model was in 20% (589 of 2998) of the trials registered. There were 36% (1083 of 2998) completed trials, of which 3% (94 of 1083) had results available in the registry. The most dominant funding source indicated was self-funding in 23% (693 of 2998) of the registered trials, and 55% (1639 of 2998) had no funding.

Conclusion: Registration on PACTR continues to grow; however, our analysis shows that researchers' capacity-building is needed to understand the importance of the registry and how this information informs healthcare decisions. Promoting prospective trial registration remains critical to avoid selective reporting bias to inform research gaps.

Keywords: clinical trials; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Number of retrospective and prospective registrations on PACTR by year. We conducted a descriptive analysis of the trials registered in PACTR and showed the number of trials registered per year on the x axis. The orange bar represents trials flagged as prospective registration, and the blue bar represents trials flagged as retrospective upon registration. The y axis represents the number of trials. PACTR, Pan African Clinical Trials Registry.
Figure 2
Figure 2
An assessment of the trials registered in the year 2020. We describe the number of trials registered in 2020 presented as a pie chart indicated in orange and green colours. The green pie represents the COVID-19 trials which are further expanded to show the different interventions of these trials in different colour shades.
Figure 3
Figure 3
Type of intervention used for the registered trials in PACTR. The trials registered indicate the intervention being investigated in their record. We describe the intervention of all the trials registered at the time of analysis. The results are represented as a bar graph indicating the number of trials with a specific intervention. The total number of trials for a particular intervention is presented at the top of each bar. PACTR, Pan African Clinical Trials Registry.
Figure 4
Figure 4
Disease conditions investigated in PACTR-registered trials. An investigation of the disease categories is represented as bar graphs on the y axis. The number of trials registered to investigate a specific disease condition is presented on the bar. PACTR, Pan African Clinical Trials Registry.
Figure 5
Figure 5
Completed trials with results in PACTR. We describe the number of registered trials with a ‘complete’ status represented with the red bar and the actual number of the trials presented as N at the bottom of the bar. The blue bar represents the number of trials with available results, and the grey bar represents the completed trials without results. PACTR, Pan African Clinical Trials Registry.
Figure 6
Figure 6
Trends in results reporting over the years. We describe the reporting section of the registered trials from 2008 to 2021 presented in bars. The dark green bar indicates trial records in which the reporting section was not completed. The lighter green represents the trials that indicated ‘no’ to reporting results. Light blue indicates registered trials with results reported. The yellow bar represents the records of undecided results to report the results. The y axis is the total number of trials.

References

    1. Abrams A, Siegfried N. The pan African clinical trials registry: year one data analysis of the only African member of the world Health organization network of primary registries. J Evid Based Med 2010;3:195–200. 10.1111/j.1756-5391.2010.01099.x - DOI - PubMed
    1. Abrams A, Siegfried N. Growing everyday: the pan African clinical trials registry. J Evid Based Med 2011;4:172–8. 10.1111/j.1756-5391.2011.01139.x - DOI - PubMed
    1. Abrams AL. One of a kind-the Pan African Clinical Trials Registry, a regional registry for Africa. Pan Afr Med J 2011;9:42. 10.4314/pamj.v9i1.71221 - DOI - PMC - PubMed
    1. Isaakidis P, Swingler GH, Pienaar E, et al. . Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ 2002;324:702. 10.1136/bmj.324.7339.702 - DOI - PMC - PubMed
    1. Abrams A, Siegfried N. A pan African clinical trials Registry for the specific needs of triallists on the continent. S Afr Med J 2010;100:292–5. 10.7196/SAMJ.3933 - DOI - PubMed

Publication types